Nuclear Pharma Danmark ApS: Financial statements 2017
CVR: 37815578
Source: annual report 2017, Danish Business Authority
14/06/2016 – 30/06/2017
Nuclear Pharma Danmark ApS (CVR 37815578) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -20,948 and a net result of DKK -21,200. Equity in the 2017 report amounted to DKK 30,346. The solvency ratio was 58.9%.
- Gross Profit
- DKK -20,948
- Profit/Loss
- DKK -21,200
- Equity
- DKK 30,346
- Total Assets
- DKK 51,546
Official annual report
Keep an eye on Nuclear Pharma Danmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Nuclear Pharma Danmark ApS
Nuclear Pharma Danmark ApS was a Danish company of the type Anpartsselskab based in Odder, founded in 2016. The company has been dissolved on 29 July 2019. The company was registered under the industry Specialiseret engroshandel med fødevarer i.a.n.. In 2018, the company reported a gross profit of DKK -6,000 and a net result of DKK -5,271 compared with DKK -21,200 the year before. Equity in the 2018 report amounted to DKK 25,075.